Novo Nordisk A/S (NONOF)

Other OTC - Other OTC Delayed Price. Currency in USD
44.31-1.49 (-3.26%)
At close: 1:25 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close45.80
Bid0.00 x
Ask0.00 x
Day's Range44.24 - 45.00
52wk Range44.24 - 46.40
1y Target EstN/A
Market Cap112.38B
P/E Ratio (ttm)20.97
Avg Vol (3m)110,183
Dividend & Yield1.41 (3.19%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters5 days ago

    Novo Nordisk to supply insulin at discount to poorest nations

    The company, which produces almost half of the world's insulin, said the guarantee applied to Least Developed Countries as defined by the United Nations, other low-income nations as defined by the World Bank, and selected organizations providing relief in humanitarian situations. "We guarantee that we will provide low-priced human insulin to ensure access to quality treatments for patients in the poorest parts of the world for many years to come," the company said in a statement. Novo promised that the cost of the medicine would not exceed 20 percent of the list prices charged for human insulin in developed nations.

  • Bloomberg7 days ago

    ‘Holy Grail’ of Oral Insulin Gives Way to Other Tablets at Novo

    More than 30 years after diabetics began injecting themselves with the modern form of insulin, treatments in a pill seem as elusive as ever.

  • There's something odd about the way insulin prices change
    Business Insider9 days ago

    There's something odd about the way insulin prices change

    Insulin prices are rising — increases that mean some people are spending as much on monthly...